Association Between Reduced Levels of Alkaline Phosphatase and Survival Times...
There is no significant difference in long-term survival between patients with PSC given UDCA (17–23 mg/kg/day) or placebo for 5 years. However, patients who have reduced or normal levels of ALP have...
View ArticleUpdate on primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) remains one of the most challenging conditions of clinical hepatology. There has been a steady growth in research to overcome this fact and the present review aims...
View ArticlePathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and...
We review our current understanding of this enigmatic disorder and discuss important topics for future studies. via Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and...
View Article